EUVIMEDEUVIMED entdecken
Multizentrische StudieQuerschnittstudieOpen Access · CC BY 4.0

Multi-level determinants of tuberculosis treatment completion in rural Uganda: A cross-sectional study

Munanura Turyasiima iD, Daniel Muliika, Gaston Turinawe, Miriam Acheng, Antony Ikiriza, Agnes Alinde, Precious Natureeba, Amon Nkwansiibwe, Balbina Gillian Akot, Susan Wendy Wandera Kayizzi, Derrick Asaasira, Shamim Nantege und 4 weitere

PLOS One · 20.04.2026 · 21 (4) · e0347022

DOI: 10.1371/journal.pone.0347022 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS One, online erschienen am 20.04.2026. Verfasst von Munanura Turyasiima und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Standards Accreditation and Patient Protection, Ministry of Health, Kampala, Uganda. Hauptthemen laut MEDLINE: Tuberculosis, Antitubercular Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tuberculosis (TB) treatment completion rates in high-burden countries like Uganda often fall short of the WHO End TB Strategy target of ≥90%. This study evaluated multilevel determinants of treatment completion to guide evidence-based improvement strategies in rural Western Uganda.

Methods

We conducted a cross-sectional, multi-center analytical study of 224 patients with drug-susceptible TB across four public health facilities in Kakumiro District. Eligible participants had been on treatment for at least six months. Data collected via structured questionnaires were validated against facility TB registers. Multivariable logistic regression identified independent predictors, reported as adjusted odds ratios (AOR) with 95% confidence intervals (CI).

Results

The treatment completion rate was 82.6% (185/224), with a 30.4% TB-HIV co-infection rate. Significant positive predictors included high TB knowledge (AOR = 14.0; 95% CI: 3.06–24.5), high economic status (AOR = 7.2; 95% CI: 1.63–31.5), belief in treatment efficacy (AOR = 6.2; 95% CI: 2.02–18.8), and respectful health worker behavior (AOR = 5.0; 95% CI: 2.15–11.83). Community-level support was critical, specifically religious/community leader advocacy (AOR = 4.2; 95% CI: 1.84–9.51) and community health worker (CHW) home visits (AOR = 3.5; 95% CI: 1.64–7.72). Waiting time less than 30 minutes (AOR = 6.3, 95% CI: 1.91–20.96) also positively impacted TB treatment completion. Major negative predictors were male gender (AOR = 0.3; 95% CI: 0.11–0.86), drug stockouts (AOR = 0.3; 95% CI: 0.11–0.70), belief in traditional cures (AOR = 0.3; 95% CI: 0.13–0.71), and stigma (AOR = 0.4; 95% CI: 0.16–0.80).

Conclusion

Achieving the WH O End TB targets requires integrated, multilevel interventions. Efforts should focus on male-targeted engagement, strengthening supply chains to eliminate drug stockouts, enhancing CHW-led community outreach, and reducing stigma to ensure equitable treatment success.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TuberculosisAntitubercular AgentsHumansUgandaCross-Sectional StudiesMaleFemaleRural PopulationAdultMiddle AgedYoung AdultHIV InfectionsAdolescent

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Standards Accreditation and Patient Protection, Ministry of Health, Kampala, Uganda.
  • Faculty of Clinical Medicine and Dentistry, Kampala International University, Kampala, Uganda.
  • Faculty of Health Sciences, Uganda Martyrs University, Kampala, Uganda.
  • Division of STD/AIDs Control, Ministry of Health, Kampala, Uganda.
  • Department of Educational Foundations and Psychology, Mbarara University of Science and Technology, Mbarara, Uganda.
  • Department of Health Sciences, Faculty of Science and Technology, Cavendish University Uganda, Kampala, Uganda.

ORCID-Profile: Munanura Turyasiima, Ronald Kooko

Zitieren

APA

Turyasiima, M., Muliika, D., Turinawe, G., Acheng, M., Ikiriza, A., Alinde, A., Natureeba, P., Nkwansiibwe, A., Akot, B. G., Wandera Kayizzi, S. W., Asaasira, D., Nantege, S., Oode, I. D., Wesonga, H. B., Atuhaire, R. K., & Kooko, R. (2026). Multi-level determinants of tuberculosis treatment completion in rural Uganda: A cross-sectional study. PLOS One, 21(4), e0347022. https://doi.org/10.1371/journal.pone.0347022

Vancouver

Turyasiima M, Muliika D, Turinawe G, Acheng M, Ikiriza A, Alinde A, et al. Multi-level determinants of tuberculosis treatment completion in rural Uganda: A cross-sectional study. PLOS One. 2026;21(4):e0347022. doi:10.1371/journal.pone.0347022

BibTeX
@article{Turyasiima2026,
  author = {Turyasiima, Munanura and Muliika, Daniel and Turinawe, Gaston and Acheng, Miriam and Ikiriza, Antony and Alinde, Agnes and Natureeba, Precious and Nkwansiibwe, Amon and Akot, Balbina Gillian and Wandera Kayizzi, Susan Wendy and Asaasira, Derrick and Nantege, Shamim and Oode, Iloit Daniel and Wesonga, Hilda Barbara and Atuhaire, Raymond Kamara and Kooko, Ronald},
  title = {Multi-level determinants of tuberculosis treatment completion in rural Uganda: A cross-sectional study},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {e0347022},
  doi = {10.1371/journal.pone.0347022}
}
Kostenlos starten →